2017 MSK Cardio-Oncology Symposium: Cardiovascular Health and Disease During and After Cancer Therapy - A Case Based Curriculum

Over the past decade, the cardiovascular care of patients with cancer has evolved as a subspecialty driven by novel therapies that can cure or control patients, allowing many patients to be living  long enough to experience the potential cardiotoxic effects of these treatments. The purpose of this conference is to provide a case-based curriculum that addresses important clinical topics relevant to the cardiovascular health of patients with cancer.  Clinical experts from Memorial Sloan Kettering Cancer Center and around the country will present an up-to-date overview on the best practice strategies in the  evaluation and management of heart disease in cancer patients from early diagnosis, treatment and long-term surveillance.  All presentations will include devoted time to permit interaction between audience members and presenters. 

There will be a separate hands on, computer-based session on advanced echo imaging techniques of strain imaging and 3D quantification of left ventricular function in cardio-oncology.

This course is intended for cardiologists, internists, hematologists/oncologists and other affiliated healthcare professionals who are involved in the care of cancer patients or have a special interest in this area.

Sponsors

Memorial Sloan Kettering gratefully acknowledges the following organizations for providing educational grants, financial support, or in-kind donation for this live activity:

• AstraZeneca Pharmaceuticals LP
• Bristol-Myers Squibb
• GE Healthcare
• Lantheus Medical Imaging
• TOMTEC CORPORATION

1. State the commonly used cancer therapy regimens associated with cardiotoxicity including novel targeted therapies
2. Recognize the cardiovascular concerns with conventional and newer targeted therapy used to treat cancer and the timeline of cardiotoxicity manifestation
3. State specific examples of cardiovascular challenges during cancer therapy
4. Illustrate the utility of preclinical biomarkers and imaging modalities for cardiotoxicity monitoring
5. Define the strengths and weaknesses of each imaging technique in the detection and prediction of cardiotoxicity
6. Describe primary and secondary prevention of cardiovascular disease in cancer patients during and after cancer therapy
7. Discuss the implementation of cardio-oncology practice guidelines to formulate best practice strategies
8. State the goals and principles of a multidisciplinary team in cardio-oncology and the approach to building a cardio-oncologic clinic
9. Evaluate the impact of cardio-oncology specialty care in the overall cardiovascular outcome of patients with cancer

Registration includes continental breakfast, lunch, and refreshment breaks. Please contact us at least one week prior to the course if you have any special dietary needs.

• 30% Discounted Rate for MSK Alumni and MSK Alliance Members 
  MSK offers a discounted rate to all MSK Alumni and MSK Alliance members to attend a CME course. Please contact [email protected] for more information or to register.
• MSK Staff Registration 
  Registration is complimentary for MSK staff who wish to attend this course. However, you must complete course registration to attend this course. 
• Learning Lab (Optional Add-On) 
  Unfortunately at this time, the Advanced Echo Imaging Learning Lab on May 13, 2017 is sold out. Please sign up to join the waitlist and we will notify you if/when additional space for the Learning Lab becomes available.

*Industry Members - Registration is for educational purposes only. Marketing, sales, and promotion of products and services are prohibited at CME activities.

Cancellation Policy

If you cancel your participation in this course, your registration fee, less a $75 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course ([email protected]).

Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

COURSE DIRECTORS

Jennifer Liu, MD

Richard M. Steingart, MD

FACULTY